FDA Drug Application (204026) for POMALYST by CELGENE

Back to FDA Applications sponsored by CELGENE

Application Number204026
Product Number001
FormCAPSULE;ORAL
Dosage1MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePOMALYST
Active IngredientPOMALIDOMIDE



Back to FDA Applications sponsored by CELGENE